Skip to main content
. 2018 Jul 3;9(51):29619–29633. doi: 10.18632/oncotarget.25651

Table 2. PCP4/PEP19 and ER categories in double positive cases.

ER+ cases ER- cases
ER %PCP ER %PCP
5+ 100 1+ 46
5+ 100 0 30
5+ 100 0 9
5+ 100 0 5
5+ 98
5+ 82
5+ 56
5+ 36
4+ 41
4+ 32
4+ 16
Mean ± SE 69.2 ± 10.0 p = 0.011 22.5 ± 9.6

ER, estrogen receptor; PCP4, PCP4/PEP19